Health Canada grants authorisation to Pfizer’s Paxlovid for Covid-19
The authorised dosage is two tablets of nirmatrelvir and one tablet of ritonavir given orally twice daily for five days.
News
Latest in
News
Medlab receives grant to develop NanoCelle nasal vaccine for Covid-19
The company will collaborate with the University of NSW and Macquarie University for vaccine development.
GSK rejects Unilever’s $68.4bn offer for Consumer Healthcare business
GSK noted that the bids ‘fundamentally undervalued’ the Consumer Healthcare business.
WHO recommends GSK-Vir and Lilly’s drugs for Covid-19 treatment
GSK-Vir’s sotrovimab was demonstrated to retain activity against Omicron variant in initial laboratory studies.
BenevolentAI and AstraZeneca expand drug discovery partnership
The companies collaborated initially in 2019 to use AI and machine learning to develop new therapies for CKD and IPF.
NICE approves lung cancer combination drug therapy for NHS use
People treated with pembrolizumab lived for 17.1 months on average versus 11.6 months for chemotherapy, trial data showed.
Covid-19 update: Repeating booster doses not viable – WHO
The global Covid death toll has passed the grim milestone of 5.5 million, with a figure of 5,510,327 according to…
South Korea grants approval to Novavax Covid-19 vaccine
SK bioscience will handle the manufacturing and commercialisation of the vaccine in South Korea.